Plain-English translation of NCT06539702 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research is testing whether simple blood work measurements and a genetic test called BRAF can reliably predict whether a thyroid nodule is cancerous. Right now, when doctors find unclear thyroid nodules, they often recommend surgery to be safe—but many of these nodules turn out to be benign (non-cancerous). This study hopes to find better ways to tell the difference before surgery.
Many people with unclear thyroid nodules undergo surgery that may not have been necessary, leading to complications, longer recovery, and extra costs. Researchers believe that examining certain blood cell counts and performing a genetic test could help doctors confidently identify which nodules are truly cancerous and which are safe to monitor instead.
You likely qualify if…
You likely don't qualify if…
If you qualify, researchers will review your blood work results from before your thyroid surgery and compare them to your final pathology results after surgery. For patients whose surgery confirms cancer, additional genetic testing (BRAF testing) will be performed on your original biopsy sample. The study is primarily a review of medical records and existing test results—you are not receiving any new experimental treatment.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Turkey (Türkiye)
Sponsor
Saglik Bilimleri Universitesi
Enrollment target
~120 participants
Started
July 2024
Primary completion
August 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 75 Years
Last updated on clinicaltrials.gov in August 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ugur 1 Kesici, Assoc. Prof.
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.